To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349
Clinical trial NCT03610867 · COMPLETED
Trial details
- NCT number
- NCT03610867
- Sponsor
- Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2017-08-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.